GU Oncology SNMMI

Study: Androgen Deprivation Therapy Does Not Affect Performance of Piflufolastat F 18-PET/CT

Piflufolastat F 18 is a radiopharmaceutical that targets the prostate-specific membrane antigen during imaging.

Curated Journal reading List

Advertisement
Advertisement

Expert Interviews